Evogene Ltd. Statistics
Share Statistics
Evogene Ltd. has 5.37M shares outstanding. The number of shares has increased by -89.39% in one year.
| Shares Outstanding | 5.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 6.07% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 5.28M |
| Failed to Deliver (FTD) Shares | 275 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 22.35K, so 0.42% of the outstanding shares have been sold short.
| Short Interest | 22.35K |
| Short % of Shares Out | 0.42% |
| Short % of Float | 0.42% |
| Short Ratio (days to cover) | 0.04 |
Valuation Ratios
The PE ratio is -15.78 and the forward PE ratio is -0.57.
| PE Ratio | -15.78 |
| Forward PE | -0.57 |
| PS Ratio | 66.81 |
| Forward PS | 0.3 |
| PB Ratio | 31.26 |
| P/FCF Ratio | -16.85 |
| PEG Ratio | n/a |
Enterprise Valuation
Evogene Ltd. has an Enterprise Value (EV) of 18.74M.
| EV / Earnings | -0.78 |
| EV / Sales | 3.32 |
| EV / EBITDA | -0.81 |
| EV / EBIT | -0.71 |
| EV / FCF | -0.84 |
Financial Position
The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.95.
| Current Ratio | 4.96 |
| Quick Ratio | 4.95 |
| Debt / Equity | 0.95 |
| Total Debt / Capitalization | 48.84 |
| Cash Flow / Debt | -1.88 |
| Interest Coverage | -230.5 |
Financial Efficiency
Return on equity (ROE) is -1.98% and return on capital (ROIC) is -65.58%.
| Return on Equity (ROE) | -1.98% |
| Return on Assets (ROA) | -0.47% |
| Return on Capital (ROIC) | -65.58% |
| Revenue Per Employee | 39.72K |
| Profits Per Employee | -168.16K |
| Employee Count | 142 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 22.26 |
Taxes
| Income Tax | -33.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -82.53% in the last 52 weeks. The beta is 1.08, so Evogene Ltd.'s price volatility has been higher than the market average.
| Beta | 1.08 |
| 52-Week Price Change | -82.53% |
| 50-Day Moving Average | 1.66 |
| 200-Day Moving Average | 4.32 |
| Relative Strength Index (RSI) | 43.41 |
| Average Volume (20 Days) | 308.66K |
Income Statement
In the last 12 months, Evogene Ltd. had revenue of 5.64M and earned -23.88M in profits. Earnings per share was -5.23.
| Revenue | 5.64M |
| Gross Profit | 1.40M |
| Operating Income | -26.39M |
| Net Income | -23.88M |
| EBITDA | -23.20M |
| EBIT | -26.39M |
| Earnings Per Share (EPS) | -5.23 |
Balance Sheet
The company has 20.77M in cash and 11.51M in debt, giving a net cash position of 9.27M.
| Cash & Cash Equivalents | 20.77M |
| Total Debt | 11.51M |
| Net Cash | 9.27M |
| Retained Earnings | -257.59M |
| Total Assets | 40.11M |
| Working Capital | 2.07M |
Cash Flow
In the last 12 months, operating cash flow was -21.58M and capital expenditures -785.00K, giving a free cash flow of -22.36M.
| Operating Cash Flow | -21.58M |
| Capital Expenditures | -785.00K |
| Free Cash Flow | -22.36M |
| FCF Per Share | -0.49 |
Margins
Gross margin is 70%, with operating and profit margins of -470% and -423.39%.
| Gross Margin | 70% |
| Operating Margin | -470% |
| Pretax Margin | -460.76% |
| Profit Margin | -423.39% |
| EBITDA Margin | -411.42% |
| EBIT Margin | -467.93% |
| FCF Margin | -396.49% |
Dividends & Yields
EVGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -344.08% |
| FCF Yield | -274.2% |
Analyst Forecast
The average price target for EVGN is $12, which is 689.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 689.5% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 25, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 25, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -10.96 |
| Piotroski F-Score | 3 |